Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.

Bottai G, Diao L, Baggerly KA, Paladini L, Győrffy B, Raschioni C, Pusztai L, Calin GA, Santarpia L.

Int J Mol Sci. 2017 Jan 19;18(1). pii: E194. doi: 10.3390/ijms18010194.

2.

MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.

Leichter AL, Sullivan MJ, Eccles MR, Chatterjee A.

Mol Cancer. 2017 Jan 19;16(1):15. doi: 10.1186/s12943-017-0584-0. Review.

3.

Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery.

Quek C, Bellingham SA, Jung CH, Scicluna BJ, Shambrook MC, Sharples RA, Cheng L, Hill AF.

RNA Biol. 2017 Feb;14(2):245-258. doi: 10.1080/15476286.2016.1270005.

4.

Long intergenic non-coding RNA expression signature in human breast cancer.

Zhang Y, Wagner EK, Guo X, May I, Cai Q, Zheng W, He C, Long J.

Sci Rep. 2016 Nov 29;6:37821. doi: 10.1038/srep37821.

5.

One Step Assembly of Thin Films of Carbon Nanotubes on Screen Printed Interface for Electrochemical Aptasensing of Breast Cancer Biomarker.

Nawaz MA, Rauf S, Catanante G, Nawaz MH, Nunes G, Marty JL, Hayat A.

Sensors (Basel). 2016 Oct 6;16(10). pii: E1651.

6.

ApoptomiRs of Breast Cancer: Basics to Clinics.

Sharma S, Patnaik PK, Aronov S, Kulshreshtha R.

Front Genet. 2016 Sep 29;7:175. Review.

7.

miRNA clusters as therapeutic targets for hormone-resistant breast cancer.

Di Leva G, Cheung DG, Croce CM.

Expert Rev Endocrinol Metab. 2015;10(6):607-617.

8.

Decoding the usefulness of non-coding RNAs as breast cancer markers.

Amorim M, Salta S, Henrique R, Jerónimo C.

J Transl Med. 2016 Sep 15;14:265. doi: 10.1186/s12967-016-1025-3. Review.

9.

Plasma exosome microRNAs are indicative of breast cancer.

Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ.

Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x.

10.

Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines.

Fiskaa T, Knutsen E, Nikolaisen MA, Jørgensen TE, Johansen SD, Perander M, Seternes OM.

PLoS One. 2016 Aug 31;11(8):e0161824. doi: 10.1371/journal.pone.0161824.

11.

Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism.

Beltrán-Anaya FO, Cedro-Tanda A, Hidalgo-Miranda A, Romero-Cordoba SL.

Front Physiol. 2016 Aug 8;7:342. doi: 10.3389/fphys.2016.00342. Review.

12.

Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer.

Devlin KL, Sanford T, Harrison LM, LeBourgeois P, Lashinger LM, Mambo E, Hursting SD.

PLoS One. 2016 Jul 19;11(7):e0159686. doi: 10.1371/journal.pone.0159686.

13.

Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells.

Duru N, Gernapudi R, Lo PK, Yao Y, Wolfson B, Zhang Y, Zhou Q.

Oncotarget. 2016 Jul 26;7(30):47511-47525. doi: 10.18632/oncotarget.10203.

14.

ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.

Napoli M, Venkatanarayan A, Raulji P, Meyers BA, Norton W, Mangala LS, Sood AK, Rodriguez-Aguayo C, Lopez-Berestein G, Vin H, Duvic M, Tetzlaff MB, Curry JL, Rook AH, Abbas HA, Coarfa C, Gunaratne PH, Tsai KY, Flores ER.

Cancer Cell. 2016 Jun 13;29(6):874-88. doi: 10.1016/j.ccell.2016.04.016.

PMID:
27300436
15.

MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen.

Tagscherer KE, Fassl A, Sinkovic T, Richter J, Schecher S, Macher-Goeppinger S, Roth W.

Cancer Cell Int. 2016 Jun 10;16:42. doi: 10.1186/s12935-016-0321-6.

16.

miR-190 Enhances HIF-Dependent Responses to Hypoxia in Drosophila by Inhibiting the Prolyl-4-hydroxylase Fatiga.

De Lella Ezcurra AL, Bertolin AP, Kim K, Katz MJ, Gándara L, Misra T, Luschnig S, Perrimon N, Melani M, Wappner P.

PLoS Genet. 2016 May 25;12(5):e1006073. doi: 10.1371/journal.pgen.1006073.

17.

Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition.

Lin CW, Lin PY, Yang PC.

Stem Cells Int. 2016;2016:2732705. doi: 10.1155/2016/2732705. Review.

18.

MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.

Matamala N, Vargas MT, González-Cámpora R, Arias JI, Menéndez P, Andrés-León E, Yanowsky K, Llaneza-Folgueras A, Miñambres R, Martínez-Delgado B, Benítez J.

Oncotarget. 2016 Apr 12;7(15):20068-79. doi: 10.18632/oncotarget.7705.

19.
20.

ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.

Ma H, Gollahon LS.

Int J Mol Sci. 2016 Jan 26;17(2). pii: E158. doi: 10.3390/ijms17020158.

Supplemental Content

Support Center